NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative ... (onal Innovation Centre. In my v...)

NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology

Date:4/3/2009

onal Innovation Centre.

"In my view the VNUS Closure procedure is the preferred technique to treat venous reflux because it requires no special modifications to operating areas, is well tolerated by patients, requires minimal post-procedure analgesia and is highly effective at permanently closing the vein," said Ian Franklin, Consultant Vascular Surgeon from Charing Cross NHS Hospital & Imperial College London.

Varicose veins are caused by increased pressure in the legs as a result of venous reflux and faulty valves in the leg veins. Left untreated, venous reflux can lead to painful varicose veins, swelling in the lower limbs, and skin problems, such as itching, redness, eczema, and leg ulcers.

For the past century, the traditional treatment for varicose veins has been a technique called vein stripping, which is carried out under general anaesthesia in operating theatres, and sometimes involves an overnight stay in a hospital bed. This treatment involves a groin incision and the complete removal of the saphenous vein, and recovery can be lengthy and uncomfortable. Surgeons in the NHS perform around 37,000 varicose vein stripping procedures every year.

The VNUS Closure procedure consists of inserting a thin radiofrequency (RF) catheter into the diseased vein through a small incision. The catheter then heats the diseased vein sequentially in 7-centimeter segments, sealing it from the inside and effectively closing it down. Blood returning to the heart then naturally reroutes through healthy veins containing normal valves.

"We are delighted that the NHS National Innovation Centr
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
2. Mayo Clinic: Retired National Football League Linemen Have High Incidence of Sleep Apnea
3. DaVita Abstracts Accepted Into National Kidney Foundations 2009 Spring Symposium
4. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
5. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
6. Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. VIDEO from Medialink and International HIFU: New Prostate Cancer Procedure Being Tested in US Clinical Trials
9. Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients
10. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
11. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells

Post Your Comments:

NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative ...(onal Innovation Centre. In my v...),Health